Record Details

<p>Patent Infringement by ANDA Filing</p>

Online Publishing @ NISCAIR

View Archive Info
 
 
Field Value
 
Authentication Code dc
 
Title Statement <p>Patent Infringement by ANDA Filing</p>
 
Added Entry - Uncontrolled Name Pohl, Mark ; Registered Patent Attorney Pharmaceutical Patent Attorneys, Llc 55 Madison Avenue, 4th Floor Morristown, Nj 07960-7397 USA
 
Uncontrolled Index Term Generic drug; generic pharmaceutical; ANDA; Abbreviated New Drug Application; infringement; patent infringement; artificial infringement; Hatch-Waxman; pharmaceutical patent infringement.
 
Summary, etc. <p>Courts are in general designed to adjudicate past events (e.g., crimes and torts which have already occurred).  Thus, for example, proving patent infringement merely requires showing the court the on-market product, and comparing it to the patent at issue.  United States law, however, provides for a fundamentally-different kind of infringement: potential future infringement by a future generic pharmaceutical product which does not yet exist because it has not yet been approved for marketing.  This type of infringement requires U.S. courts to adjudicate <em>future</em> events, predicting the likely characteristics of the future generic pharmaceutical.  In requiring a court to adjudicate a potential future event, this type of infringement can pose a unique evidentiary challenge to judges.  This article discusses how U.S. judges evaluate potential future infringement by generic pharmaceuticals.</p>
 
Publication, Distribution, Etc. Journal of Intellectual Property Rights (JIPR)
2023-04-05 11:39:54
 
Electronic Location and Access application/pdf
http://op.niscair.res.in/index.php/JIPR/article/view/5115
 
Data Source Entry Journal of Intellectual Property Rights (JIPR); ##issue.vol## 19, ##issue.no## 3 (2014): Journal of Intellectual Property Rights
 
Language Note en
 
Nonspecific Relationship Entry http://op.niscair.res.in/index.php/JIPR/article/download/5115/11672